Fred Alger Management, LLC Ionis Pharmaceuticals Inc Transaction History

Fred Alger Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $455,074 - $541,495	10,488 Added 77.31%	24,054 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $522,291 - $639,365	13,566 New	13,566 $615,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $6.38 Million - $7.82 Million	-189,854 Reduced 99.74%	499 $17,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $1.78 Million - $2.23 Million	47,831 Added 33.56%	190,353 $7.19 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $151,056 - $201,160	-4,134 Reduced 2.82%	142,522 $6.3 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $4.65 Million - $6.31 Million	146,656 New	146,656 $5.43 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $10,231 - $12,401	-190 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $14,174 - $17,316	-240 Reduced 55.81%	190 $11,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $11,735 - $16,280	189 Added 78.42%	430 $28,000
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $12,753 - $19,561	241 New	241 $20,000
Q2 2018 Jul 19, 2018	SELL	$40.53 - $50.7 $162,120 - $202,800	-4,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$44.08 - $55.05 $176,320 - $220,200	4,000 New	4,000 $176,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.